Cyclophosphamide
- Product NDC
- 70121-1240
- 11-digit product format
- 701211240
- Labeler code
- 70121
- Product ID
- 70121-1240_40ce8341-9b51-4187-920b-ad9cce7930e1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclophosphamide
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS; ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA210046
- Marketing category
- ANDA
- Marketing start
- 2018-05-31
- Substance
- CYCLOPHOSPHAMIDE
- Active strength
- 2 g/100mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cyclophosphamide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOPHOSPHAMIDE | 2 g/100mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8N3DW7272P |
| Rxcui | 1734917, 1734919, 1734921 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70121-1240-1 | Cyclophosphamide | 100 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 100 | | 13 |
| 70121-1240-1 | Cyclophosphamide | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | | 13 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70121-1240 | CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [AMNEAL PHARMACEUTICALS LLC] | 10 | Current NDC, Legacy NDC, 2 package rows | 20241207_520bfe39-dfd5-4a20-9a37-80078afded0d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70121-1240-1 | 70121124001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-1240-1) / 100 mL in 1 VIAL, SINGLE-DOSE | 2018-05-31 | 0000-00-00 | No | No | Current |